top of page

ACCELERATING NOVEL SCIENCE
TO CREATE NEW MEDICINES

At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases.

Embryonic Stem Cells

INVESTMENT FOCUS

The Global BioAccess Fund invests in companies developing novel therapeutics and devices to address serious unmet medical needs in oncology, rare disease, CNS and cardiology. We fund early-stage companies who need capital to support IND submission and clinical trials.

CONTACT

For more information about the Global BioAccess Fund please contact us at info@globalbioaccess.com

bottom of page